<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">33987042</PMID><DateRevised><Year>2021</Year><Month>05</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>4</Issue><PubDate><Year>2021</Year><Month>Apr</Month><Day>07</Day></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Enhanced External Counterpulsation as a Novel Treatment for Post-acute COVID-19 Sequelae.</ArticleTitle><Pagination><StartPage>e14358</StartPage><MedlinePgn>e14358</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e14358</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.14358</ELocationID><Abstract><AbstractText>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus responsible for the coronavirus disease 2019 (COVID-19) pandemic. As patients recover from COVID-19, some continue to report persisting symptoms weeks to months after acute infection. These effects have been referred to as post-acute sequelae of SARS-CoV-2 infection (PASC). We report the case of a 38-year-old woman suffering from PASC symptoms following acute COVID-19 in October 2020. During her acute infection phase, she had a home recovery and reported her predominant symptoms as fatigue, headaches, body pain, and shortness of breath. After most of her symptoms were resolved, she continued to have periodic episodes of fatigue and headaches, along with random shortness of breath while at rest and during activities for months beyond the acute phase of the illness. She also noted the presence of "brain fog," as if lacking the same clarity that she had prior to her illness. These symptoms persisted for three months before the patient underwent enhanced external counterpulsation (EECP) therapy in one-hour sessions, three times per week. This therapy was chosen based on the mechanism of action of EECP benefiting patients with ischemic cardiovascular diseases. After one week, her "brain fog" had improved, with shortness of breath improving after 1.5 weeks. The patient reported returning to pre-COVID health and fitness after approximately five weeks of EECP treatment. To our knowledge, this is the first case of using EECP for post-COVID shortness of breath, fatigue, and "brain fog."</AbstractText><CopyrightInformation>Copyright &#xa9; 2021, Dayrit et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dayrit</LastName><ForeName>Joshua Kyle</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, University of the Pacific, Stockton, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verduzco-Gutierrez</LastName><ForeName>Monica</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation Medicine, Joe R. and Teresa Lozano Long School of Medicine at University of Texas Health San Antonio, San Antonio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teal</LastName><ForeName>Ann</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Medical Affairs, Flow Therapy, Fort Worth, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Sachin A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Medical Affairs, Flow Therapy, Fort Worth, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>04</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">covid-19</Keyword><Keyword MajorTopicYN="N">eecp</Keyword><Keyword MajorTopicYN="N">enhanced external counterpulsation</Keyword><Keyword MajorTopicYN="N">long covid</Keyword><Keyword MajorTopicYN="N">pasc</Keyword></KeywordList><CoiStatement>The authors have declared financial relationships, which are detailed in the next section.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>14</Day><Hour>7</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>4</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33987042</ArticleId><ArticleId IdType="pmc">PMC8110286</ArticleId><ArticleId IdType="doi">10.7759/cureus.14358</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network - United States, March-June 2020. Tenforde MW, Kim SS, Lindsell CJ, et al. MMWR Morb Mortal Wkly Rep. 2020;69:993&#x2013;998.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Huang C, Huang L, Wang Y, et al. Lancet. 2021;397:220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19) Puntmann VO, Carerj ML, Wieters I, et al. JAMA Cardiol. 2020;5:1265&#x2013;1273.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Impact of coronavirus disease 2019 on pulmonary function in early convalescence phase. Huang Y, Tan C, Wu J, et al. Respir Res. 2020;21:163.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7323373</ArticleId><ArticleId IdType="pubmed">32600344</ArticleId></ArticleIdList></Reference><Reference><Citation>The landscape of cognitive function in recovered COVID-19 patients. Zhou H, Lu S, Chen J, et al. J Psychiatr Res. 2020;129:98&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7324344</ArticleId><ArticleId IdType="pubmed">32912598</ArticleId></ArticleIdList></Reference><Reference><Citation>Long-term micro-structure and cerebral blood flow changes in patients recovered from COVID-19 without neurological manifestations [Online ahead of print] Qin Y, Wu J, Chen T, et al. J Clin Invest. 2021</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8262559</ArticleId><ArticleId IdType="pubmed">33630760</ArticleId></ArticleIdList></Reference><Reference><Citation>Enhanced external counterpulsation therapy: past, present, and future. Raza A, Steinberg K, Tartaglia J, Frishman WH, Gupta T. Cardiol Rev. 2017;25:59&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">27548685</ArticleId></ArticleIdList></Reference><Reference><Citation>Enhanced external counterpulsation efficacy on exercise endurance in COPD patients and healthy subjects: a pilot randomized clinical trial. Zhao M, Huang Y, Li L, et al. Int J Chron Obstruct Pulmon Dis. 2020;15:25&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6954827</ArticleId><ArticleId IdType="pubmed">32021141</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>